Form 4: Repligen Director Margaret Pax Reports Stock and Option Awards

Director Margaret Pax reports the acquisition of restricted stock units and stock options in Repligen Corporation.

Summary

• On May 15, 2025, Margaret Pax, a director of Repligen Corporation, reported the acquisition of 973 restricted stock units and 1,800 stock options.
• The restricted stock units represent a contingent right to receive one share of Repligen Corporation's common stock and vest on the earlier of May 15, 2026, or the date of the next annual meeting.
• The stock options have an exercise price of $123.26 and vest on the earlier of May 15, 2026, or the date of the next annual meeting, expiring on May 15, 2035.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. It reflects standard executive compensation practices, aligning director interests with shareholders. There are no indications of negative events or concerns.

Positives

• The grant of stock options and restricted stock units to a director aligns their interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the director.

Future Outlook

The restricted stock units vest on the earlier of May 15, 2026, one year from the grant date, or the date of the next annual meeting of the Company's shareholders, which has not yet been determined.

Industry Context

Stock options and restricted stock units are common forms of executive compensation in the biotechnology industry, aligning management's interests with those of shareholders and incentivizing long-term value creation.

Comparison to Industry Standards

• Stock option grants are a standard component of compensation packages for directors and executives in publicly traded companies, particularly in growth-oriented sectors like biotechnology.
• The vesting period of one year is fairly typical, aligning with industry norms for incentivizing sustained performance and commitment.
• Companies like Amgen, Biogen, and Gilead Sciences also utilize stock options and restricted stock units as part of their executive compensation plans.

Stakeholder Impact

• The grant of equity to a director can positively impact shareholders by aligning management's interests with long-term value creation.
• Employees may view the equity grants as a positive sign of the company's commitment to its leadership.

Next Steps

• The director will receive shares of Repligen Corporation's common stock upon vesting of the restricted stock units.
• The director may exercise the stock options after they vest, subject to the terms of the option agreement.

Key Dates

Keywords

Repligen, Director, Stock Options, Restricted Stock Units, Form 4, Beneficial Ownership, Equity Securities